CONFLICT OF INTEREST

Sharif H. Hegazy, Jesper Qvist Thomassen, Ida Juul Rasmussen, and Anne Tybjærg-Hansen have nothing to disclose. Børge G. Nordestgaard received consulting fees (personal fees) from AstraZeneca, Sanofi, Regeneron, Akcea, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, and Silence Therapeutics. RFS received consulting fees (personal fees) from Novo Nordisk. The Lundbeck Foundation, the Danish Heart Foundation, and the Independent Research Fund Denmark. Author disclosures are available in the supporting information.

中文翻译：

---

C反应蛋白水平和阿尔茨海默病风险的观察和遗传研究

利益冲突

Sharif H. Hegazy、Jesper Qvist Thomassen、Ida Juul Rasmussen 和 Anne Tybjærg-Hansen 没有什么可以透露的。Børge G. Nordestgaard 从 AstraZeneca、Sanofi、Regeneron、Akcea、Amgen、Kowa、Denka、Amarin、Novartis、Novo Nordisk、Esperion 和 Silence Therapeutics 收取咨询费（个人费用）。RFS 从诺和诺德收取咨询费（个人费用）。Lundbeck 基金会、丹麦心脏基金会和丹麦独立研究基金。支持信息中提供了作者披露。